首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
【24h】

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

机译:DMARD逐渐减量治疗通过类风湿关节炎患者的多种生物标志物疾病活性和自身抗体状态来预测疾病的复发

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To analyse the role of multibiomarker disease activity (MBDA) score in predicting disease relapses in patients with rheumatoid arthritis (RA) in sustained remission who tapered disease modifying antirheumatic drug (DMARD) therapy in RETRO, a prospective randomised controlled trial.
机译:目的分析多生物标志物疾病活动性(MBDA)评分在风湿性关节炎(RA)持续缓解中的风湿性关节炎(RA)患者中的作用,该患者在RETRO中进行了渐进性疾病改良抗风湿药(DMARD)治疗,这是一项前瞻性随机对照试验。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号